@_backtableONC
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
A multidisciplinary podcast for healthcare professionals who provide cancer care!
San Diego, CA
Joined November 2024
- Tweets261
- Following722
- Followers273
- Likes541
BackTable Tumor Board retweeted
How can urologists move past a one-size-fits-all approach to PSA?
Dr. Tarik Benidir (@TarikBenidir) and Dr. Ruchika Talwar (@RuchikaTalwarMD) discuss smarter use of repeat testing, patient education, and why age and prostate size are key context clues.
Access the full episode in the BackTable app:
backtable.com/shows/urology/…
This podcast is supported by Cleveland Diagnostics.
#URO325 #ProstateCancer #PSATesting #ProstateBiopsy #UrologicOncology @UF_Urology @VUMChealth
BackTable Tumor Board retweeted
Moores Cancer Center member Ludmil Alexandrov, PhD, shares his research and vision for the future of cancer prevention in a new Q&A with Cancer Grand Challenges.
Learn more about his work and the global initiative advancing cancer research.
Full Article: bit.ly/4xAzOih
BackTable Tumor Board retweeted
Happy to share our original publication ascopubs.org/doi/10.1200/PO-…
@montypal @jgong15 @ronanhsieh @DanengLi @OncoAlert @gagan_brar24 @SteveMaronMD @GastroRes @StoCANcer
BackTable Tumor Board retweeted
We are looking forward to hosting our 2nd Annual @VUMCDiscoveries #YoungAdult #Cancer
C-BEYOND Symposium!
▶️#Colorectal #Genitourinary #SupportiveCare
▶️Meet and Greet 11/13/2026 #PrintingHouseHotel
▶️Symposium Date: 11/14/2026
▶️ Venue: @listeningroom #Nashville
▶️8AM - 3PM
▶️Registration: 2026YACSymposium.eventbrite.…
#Visitingfaculty: #YinCao @washumedicine #GabrielaMontenegro @NIH @fumikochino @UTMDAnderson
#PatientPanel: @mholtzonline #TrevorMaxwell @Survivor_Fit @ctycka @FightCRC @justinlevenson
@wwp
#patientadvocate #PatientCare #psychoncology #sexualfunction #financialtoxicity #cancergenetics #exposome
ALT This event is designed to support and empower young adults affected by cancer. With a focus on #Colorectal, #Genitourinary, and #supportivecare, the Symposium will highlight the unique challenges faced by young adult patients, survivors, and advocates. Through expert-led conversations and shared experiences, we will explore opportunities to strengthen care, expand support, and improve outcomes for this community.
BackTable Tumor Board retweeted
Enjoyed this recent @GiOncNow Biomarker Summit roundtable w/esteemed colleagues in #breast & #GI oncology @PTarantinoMD @drsarahsam @DrKEMcCann Dr. Christopher Lieu @BGriebMD on what we can learn from each other about biomarkers #ctDNA & #MRD
docwirenews.com/page/biomark…
@OncoAlert
When brain mets are no longer a death sentence, what comes first: radiation, surgery, or systemic therapy?
On BackTable Tumor Board, Dr. Barbara O’Brien (@barbaraobrienmd) and Dr. Lindsay Peterson discuss the evolving approach to CNS disease in breast cancer, including how treatment sequencing, multidisciplinary care, and new systemic options are changing outcomes for patients.
Listen now with the BackTable App: na2.hubs.ly/H07SHTT0
#ONC81 #BreastCancer #NeuroOncology #BrainMets #LeptomeningealDisease @UTMDAnderson @SitemanCenter @ASCO
BackTable Tumor Board retweeted
Save the Date! Sept 26-27th: #GI #cancer #GreatDebates updates! My co-Chair @YJanjigianMD; Drs. Alese and Chan; @Sam_Cytryn @efratdotan @sepideh_gholami @KlempnerSam @rutikamehtaMD and Kevin Soares. #GDUS26 #cancerresearch
BackTable Tumor Board retweeted
How do you balance surveillance, symptom relief, and patient preference when tumors keep coming back?
Dr. Charles Peyton (@ccp1983) and Dr. Ruchika Talwar (@RuchikaTalwarMD) share their real-world strategy for managing pesky bladder cancer in the community, from clinic ablation to the decision for TURBT.
Access the full episode in the BackTable app:
backtable.com/shows/urology/…
#URO323 #BladderCancer #NMIBC #TURBT @VUMCDiscoveries @UABUrology
BackTable Tumor Board retweeted
What’s the best way to pair Y90 and immunotherapy for liver cancer?
Dr. Beau Toskich (@BeauToskichMD), Dr. Lingling Du, and Dr. Tyler Sandow (@bayouteazy) discuss real-world timing, how to handle side effects, and why patient needs and institutional workflow often guide the sequencing choice.
Access the full episode in the BackTable app:
backtable.com/shows/vi/podca…
This podcast is supported by an educational grant from Sirtex and Boston Scientific.
#VI659 #HCC #Y90 #HCCCreatorWeekend #Immunotherapy @MayoClinicFL_IR @OchsnerHealth @AaronFrittsMD @beckcj
BackTable Tumor Board retweeted
Are you living with small cell lung cancer (SCLC)? Join us for our monthly Small Cell Smashers YouTube Live on 9/22!
Dr. Benjamin Morris will discuss his research, the IASCLC Young Investigators group, and how their work can help those with SCLC. youtube.com/lungevityfoundat…
BackTable Tumor Board retweeted
@NatureCancer thank you for highlighting our phase I trial of high-dose L-glutamine + #1L gemcitabine/nab-paclitaxel in #mPDAC
@OncoAlert @OmVenture @letswinpc @oncodaily @OncoDailyGI @OncUpdates @OncologyNT @OncNewsCentral @OncBrothers @CancerNetwrk @Onco_Nexus @_backtableONC
🚨New in Nature Cancer
Dr Gong and colleagues report findings from the phase 1 study evaluating L-glutamine + gemcitabine/nab-paclitaxel in untreated advanced PDAC. ORR 44%, including 12.5% CR, with median OS of 22 months. #PancreaticCancer @jgong15
nature.com/articles/s43018-0…
How do you approach clinically node-negative penile cancer when deciding on imaging, biopsy, and lymph node management?
This week’s Case Highlight features Drs. Juanita Crook, Andrea Apolo (@apolo_andrea), and Charles Peyton (@ccp1983) discussing imaging preferences, biopsy, and lymph node dissection in patients with penile cancer.
Explore this case and more clinical discussions in the BackTable App: na2.hubs.ly/H07L98h0
#PenileCancer #Urology #Oncology #LymphNodeDissection @NIH
@UABUrology @Kate_Baker_MD
BackTable Tumor Board retweeted
Can keeping gemcitabine in the bladder longer boost results for BCG unresponsive NMIBC?
Dr. Sarah Psutka (@spsutkaMD) and Dr. Ruchika Talwar (@RuchikaTalwarMD) discuss the science, patient conversations, and what sets this new intravesical device apart.
Access the full episode in the BackTable app:
backtable.com/shows/urology/…
This podcast is supported by Johnson & Johnson.
#URO320 #BladderCancer #NMIBC #IntravesicalTherapy #GEMiRDS @VUMChealth @uwurology @EUplatinum
When is less actually more with immunotherapy for metastatic colorectal cancer?
Dr. Cathy Eng (@CathyEngMD) and Dr. Jun Gong (@jgong15) share how patient frailty, BRAF status, and the latest trial data shape their first-line decisions for MSI-high disease.
Access the full episode in the BackTable app: backtable.com/shows/tumor-bo…
This podcast is supported by Bristol Myers Squibb.
#ONC75 #ColorectalCancer #Immunotherapy #mCRC #ClinicalTrial @Kate_Baker_MD @VUMCDiscoveries @CedarsSinai
BackTable Tumor Board retweeted
#SickleCellAnemia Awareness newschannel5.com/plus/mornin… @VUMChealth @VUMCDiscoveries @DrAdetolaKassim
They discuss the importance of blood donations and knowing your trait status:
Upcoming event:
Sickle Cell Community Health Event
Saturday, September 19th, 2026 | 10 AM – 2 PM
Jefferson Street Missionary Baptist Church
2708 Jefferson St, Nashville, TN
615-329-2990
jsmbc.org
Vein to vein in about a third of the published time.
Dr. Mike Byrne of Tennessee Oncology (@TNOncology) joins Aaron Lyss on BackTable Tumor Board to talk about who a community cell therapy program actually reaches and where the science is heading next. Faster evaluation, faster apheresis, and treatment close to home.
Tune in now to Episode 2 of the Cellular Therapy in Community Oncology Miniseries with the BackTable App: na2.hubs.ly/H07Js3T0
#ONC80 #CARTCellTherapy #CellTherapy #CommunityOncology @OneOncology @Kate_Baker_MD
BackTable Tumor Board retweeted
Read the backstory behind the phase I GlutaPanc trial in this @NatureCancer #ResearchBriefing, including challenges in funding this unconventional therapy in #PDAC when glutamine deprivation, not supplementation, was the historical approach
nature.com/articles/s43018-0…
@OncoAlert
BackTable Tumor Board retweeted
How does immunotherapy wake up the immune system to fight hepatocellular carcinoma, and what’s the real impact of combination therapy trials?
Dr. Beau Toskich (@BeauToskichMD), Dr. Lingling Du, and Dr. Tyler Sandow (@bayouteazy) break down checkpoint inhibitors, adverse events, and why controlling disease progression is the name of the game for challenging cases.
Access the full episode in the BackTable app:
backtable.com/shows/vi/podca…
This podcast is supported by an educational grant from Sirtex and Boston Scientific.
#VI659 #HCC #Y90 #HCCCreatorWeekend #Immunotherapy @MayoClinicFL_IR @OchsnerHealth @AaronFrittsMD @beckcj
How do you approach imaging and biopsy of a lung lesion in a patient with NSCLC?
This week’s Case Highlight features Drs. Alan Lee, Scott Oh, Robert Suh, Scott Genshaft, and Venkatesh Krishnasamy (@kavikrishVIR) discussing lung lesion imaging and biopsy techniques, with considerations for multidisciplinary management of NSCLC.
Explore this case and more clinical discussions in the BackTable App: backtable.com/shows/tumor-bo…
#LungCancer #NSCLC #InterventionalRadiology #InterventionalOncology @Kate_Baker_MD @UCLAHealth @KeckMedicineUSC
What does extended follow-up reveal about dual immunotherapy in colorectal cancer?
Dr. Cathy Eng (@CathyEngMD) and Dr. Jun Gong (@jgong15) discuss survival rates, maintenance strategies, and what these results mean for real-world patient counseling and expectations.
Access the full episode in the BackTable app: backtable.com/shows/tumor-bo…
This podcast is supported by Bristol Myers Squibb.
#ONC75 #ColorectalCancer #Immunotherapy #ClinicalTrial #CheckMate8HW @Kate_Baker_MD @VUMCDiscoveries @CedarsSinai